EXPRESSION PATTERN OF MITOCHONDRIAL ND2 GENE IN HUMAN LEUKEMIA AND IN HL-60 CELLS DURING GROWTH AND DIFFERENTIATION

被引:3
作者
DOHMEN, K [1 ]
KUDO, J [1 ]
SHIMAMURA, R [1 ]
KONDO, H [1 ]
SHIBUYA, T [1 ]
OKAMURA, S [1 ]
ISHIBASHI, H [1 ]
NIHO, Y [1 ]
机构
[1] KYUSHU UNIV,FAC MED,DEPT INTERNAL MED 1,3-1-1 MAIDASHI,HIGASHI KU,FUKUOKA 812,JAPAN
关键词
ND2; GENE; LEUKEMIA; DIFFERENTIAL EXPRESSION; HL-60; MITOCHONDRIA;
D O I
10.3109/10428199109067635
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We differentially screened 5,000 clones from a cDNA library of acute myelogenous leukemia (AML) cell line HL60 using cDNA probes derived from normal granulocytes or from acute myelomonocytic leukemia cells, the objective being to identify genes preferentially expressed in myeloid lineage leukemic cells. One clone, corresponding to a mitochondrial DNA fragment, including NADH dehydrogenase subunit 2 (ND2) gene, was selected for use as a probe. We examined expression of the ND2 gene in various leukemic cell populations and in normal peripheral blood cells. DNA-RNA hybridization studies revealed that ND2 messenger RNA (mRNA) was more markedly expressed in AML cells than in other leukemic cells and normal peripheral blood granulocytes. The expression of ND2 mRNA decreased in HL60 cells several hours after treatment with phorbol myristate acetate (PMA), or dimethyl sulfoxide (DMSO). However, the ND2 gene expression did not depend on the growth-state of HL60 cells because the steady-state level of its expression was observed during transitions of growth. These results suggest that ND2 mRNA is involved in the maturation of myeloid cells and in cellular differentiation, in a lineage-preferential manner. A comparison of the nucleotide sequence of this clone with the documented human mitochondrial DNA sequence revealed several single-base substitutions, insertions and a 39-bases insertion. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:397 / 406
页数:10
相关论文
共 31 条
[1]  
Shiosaka T., Saunders G.F., Differential expression of selected genes in human leukemia leukocytes, Proc. Natl. Acad. Sci. USA, 79, pp. 4668-4671, (1982)
[2]  
Birnie G.D., Burns J.H., Wiedemann L.M., Warnock A.M., Tindle R.W., Burnett A.K., Tansey P., Lucie N.P., Robertson M.R., A new approach to the classification of human leukemias: Measurement of the relative abundance of a specific RNA sequence by means of molecular hybridization, Lancet, 1, pp. 197-200, (1983)
[3]  
Mars W.M., Florine D.L., Talpaz M., Saunders G.F., Preferentially expressed genes in chronic myelogenous leukemia, Blood, 65, pp. 1218-1225, (1985)
[4]  
Wiedemann L.M., Francis G.E., Lamb R.F., Burns J.H., Winnie J.N., MacKenzie E.D., Birnie G.D., Differentiation stage-specific expression of a gene during granulopoiesis, Leukemia, 3, pp. 227-234, (1989)
[5]  
Narni F., Kudo J., Mars W., Calabretta B., Florine D.L., Barlogie B., Saunders G.F., HLA-DR-associated invariant chain is highly expressed in chronic lymphocytic leukemia, Blood, 68, pp. 372-377, (1986)
[6]  
Kudo J., Chao L.-Y., Narni F., Saunders G.F., Structure of the human gene encoding the invariant γ-chain of class II histocompatibility antigens, Nucl. Acids. Res, 13, pp. 8827-8841, (1985)
[7]  
Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18, pp. 5294-5299, (1979)
[8]  
Aviv H., Leder P., Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose, Proc. Natl. Acad. Sci. USA, 69, pp. 1408-1412, (1972)
[9]  
Grunstein M., Hogness D.S., Colony hybridization: A method for the isolation of cloned DNAs that contain a specific gene, Proc. Natl. Acad. Sci. USA, 72, pp. 3961-3965, (1975)
[10]  
Myers M.J., Pullen J.K., Ghildyal N., Eustis-Turf E., Schook L.B., Regulation of IL-1 and TNF-α expression during the differentiation of bone marrow derived macrophage, J. Immunol, 142, pp. 153-160, (1989)